These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1107574

  • 21. BCG immunotherapy in patients with malignant melanoma.
    Karakousis CP, Douglass HO, Yeracaris PM, Holyoke ED.
    Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125
    [Abstract] [Full Text] [Related]

  • 22. Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally active.
    Zbar B, Ribi E, Rapp HJ.
    Cancer; 1977 Dec; 40(6):2930-2. PubMed ID: 201359
    [Abstract] [Full Text] [Related]

  • 23. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y, Yoshizaki K, Azuma I, Yagura T, Watanabe T.
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [Abstract] [Full Text] [Related]

  • 24. Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer.
    Hunter JT, Ashley MP, Sukumar S, Sugimoto T, Zbar B, Rapp HJ, Yarkoni E.
    J Exp Med; 1981 Aug 01; 154(2):253-61. PubMed ID: 7264559
    [Abstract] [Full Text] [Related]

  • 25. A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.
    Yarkoni E, Hunter JT, Sukumar S.
    Cancer Immunol Immunother; 1982 Aug 01; 14(2):92-5. PubMed ID: 6965232
    [Abstract] [Full Text] [Related]

  • 26. Immunotherapy in malignant melanomaa.
    Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.
    Natl Cancer Inst Monogr; 1976 Nov 01; 44():85-6. PubMed ID: 799763
    [Abstract] [Full Text] [Related]

  • 27. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
    Eilber FR, Morton DL, Holmes EC, Sparks FC, Ramming KP.
    N Engl J Med; 1976 Jan 29; 294(5):237-40. PubMed ID: 1244548
    [Abstract] [Full Text] [Related]

  • 28. Immunotherapy of guinea pig cancer with BCG.
    Zbar B.
    Johns Hopkins Med J Suppl; 1974 Jan 29; 3():121-30. PubMed ID: 4608693
    [No Abstract] [Full Text] [Related]

  • 29. In vivo and in vitro responses of cats sensitized with viable Mycobacterium bovis (BCG).
    Legendre AM, Easley JR, Becker PU.
    Am J Vet Res; 1979 Nov 29; 40(11):1613-9. PubMed ID: 393146
    [Abstract] [Full Text] [Related]

  • 30. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
    de Jong WH, Teppema JS, Wagenaar SS, Paques M, Steerenberg PA, Ruitenberg EJ.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 Nov 29; 50(3):249-69. PubMed ID: 2870577
    [Abstract] [Full Text] [Related]

  • 31. Some immunologically based reactions that can cause the regression of large tumor masses.
    Alexander P.
    Natl Cancer Inst Monogr; 1976 Nov 29; 44():105-8. PubMed ID: 799755
    [Abstract] [Full Text] [Related]

  • 32. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    J Natl Cancer Inst; 1973 Dec 29; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract] [Full Text] [Related]

  • 33. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.
    Granger DL, Brehmer W, Brehmer W, Yamamoto K, Ribi E.
    Infect Immun; 1976 Feb 29; 13(2):543-53. PubMed ID: 770333
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct 29; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 35. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1972 Dec 29; 35():345-58. PubMed ID: 4349152
    [No Abstract] [Full Text] [Related]

  • 36. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL, Kreider JW, Purnell DM.
    J Natl Cancer Inst; 1976 Dec 29; 57(6):1297-303. PubMed ID: 794505
    [Abstract] [Full Text] [Related]

  • 37. Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin.
    Sakita M, Takenaka A, Yamane T, Kasuga M, Fujita Y, Majima S.
    Jpn J Surg; 1984 Sep 29; 14(5):413-9. PubMed ID: 6392656
    [Abstract] [Full Text] [Related]

  • 38. Immunotherapy of cancer: tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets.
    Gray GR, Ribi E, Granger D, Parker R, Azuma I, Yamamoto K.
    J Natl Cancer Inst; 1975 Sep 29; 55(3):727-30. PubMed ID: 1159851
    [Abstract] [Full Text] [Related]

  • 39. [The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].
    Schwartz E.
    Zentralbl Bakteriol Orig A; 1974 Jun 29; 226(4):497-509. PubMed ID: 4152732
    [No Abstract] [Full Text] [Related]

  • 40. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E, Rapp HJ.
    Oncology; 1982 Jun 29; 39(5):314-8. PubMed ID: 7099513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.